Loading...
healthfitnessmedicine
Semaglutide for CVD in Diabetes, PAD, and MASH, Semaglutide vs Tirzepatide, Normal Saline vs Lactated Ringer's, Oxygen Targets for Intubated Patients, Platelet Transfusion Guidelines, Apixaban vs Rivaroxaban
About this Episode
Today we do a round-up of some of the recent semaglutide trials. Does semaglutide ever miss? But what about tirzepatide, which causes even more weight loss?
We also review two new critical care trials, FLUID and the UK-ROX, new platelet transfusion guidelines, and a new retrospective study of apixaban vs rivaroxaban vs warfarin.
Oral Semaglutide for Diabetes with Cardiovascular Disease or CKD (SOUL)
Semaglutide for Peripheral Artery Disease (STRIDE)
Semaglutide for MASH (ESSENCE)
Semaglutide vs Tirzepatide for Obesity (SURMOUNT-5)
Normal Saline vs Lactated Ringers (FLUID)
Conservative Oxygen Targets in Mechanically Ventilated Patients (UK-ROX)
Platelet Transfusion Guidelines
Apixaban vs Rivaroxaban vs Warfarin
Music from Uppbeat (free for Creators!):
https://uppbeat.io/t/soundroll/dope
License code: NP8HLP5WKGKXFW2R
No transcript available for this episode.
More from Last Week in Medicine
View all episodes →
Catheter Directed Fibrinolysis for Acute PE (HI-PEITHO), NEWS2 Plus Procalcitoni...
Last Week in Medicine
Apr 7, 20261:01:27failed
Bleeding Risk with Apixaban vs Rivaroxaban for Acute VTE (COBRRA), Left Atrial A...
Last Week in Medicine
Mar 28, 202635:37completed
2026 ACC/AHA Guidelines for Acute Pulmonary Embolism
Last Week in Medicine